Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2018

Commitments and Contingencies Disclosure [Abstract]

Schedule of total future minimum lease payments under the non-cancellable operating leases

For the years ending December 31,	Amount
2019	$	600,978
2020		626,277
2021		397,842
2022		75,174
2023 and thereafter		-
Total	$	1,700,271

Schedule of milestone payments are to be made upon achievements of certain conditions

	Amount
Drug molecules: up to the conditions and milestones of
Preclinical to IND filing	$	372,564
From entering phase 1 to before first commercial sale		24,216,410
First commercial sale		15,656,410
Net sales amount more than certain threshold in a year		75,769,231
Subtotal		116,014,615
Surgical robotics and medical devices: up to the conditions and milestones of
Before FDA approval		270,000
FDA approval obtained		200,000
Subtotal		470,000
Total	$	116,484,615